- Home
- VRRM vs TVTX Comparison
VRRM vs TVTX Comparison
Compare VRRM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRRM
- TVTX
- Stock Information
- Founded
- VRRM 1987
- TVTX 2008
- Country
- VRRM United States
- TVTX United States
- Employees
- VRRM N/A
- TVTX N/A
- Industry
- VRRM Transportation Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- VRRM Consumer Discretionary
- TVTX Health Care
- Exchange
- VRRM Nasdaq
- TVTX Nasdaq
- Market Cap
- VRRM 3.7B
- TVTX 3.1B
- IPO Year
- VRRM N/A
- TVTX N/A
- Fundamental
- Price
- VRRM $22.56
- TVTX $35.18
- Analyst Decision
- VRRM Strong Buy
- TVTX Strong Buy
- Analyst Count
- VRRM 4
- TVTX 15
- Target Price
- VRRM $28.38
- TVTX $37.21
- AVG Volume (30 Days)
- VRRM 1.5M
- TVTX 2.1M
- Earning Date
- VRRM 10-29-2025
- TVTX 10-30-2025
- Dividend Yield
- VRRM N/A
- TVTX N/A
- EPS Growth
- VRRM N/A
- TVTX N/A
- EPS
- VRRM 0.32
- TVTX N/A
- Revenue
- VRRM $942,717,000.00
- TVTX $435,826,000.00
- Revenue This Year
- VRRM $11.15
- TVTX $108.68
- Revenue Next Year
- VRRM $7.03
- TVTX $40.23
- P/E Ratio
- VRRM $70.76
- TVTX N/A
- Revenue Growth
- VRRM 8.52
- TVTX 114.22
- 52 Week Low
- VRRM $19.51
- TVTX $12.91
- 52 Week High
- VRRM $27.20
- TVTX $36.76
- Technical
- Relative Strength Index (RSI)
- VRRM 36.63
- TVTX 66.12
- Support Level
- VRRM $22.53
- TVTX $33.05
- Resistance Level
- VRRM $23.27
- TVTX $36.76
- Average True Range (ATR)
- VRRM 0.89
- TVTX 1.95
- MACD
- VRRM -0.03
- TVTX -0.02
- Stochastic Oscillator
- VRRM 20.75
- TVTX 80.99
About VRRM Verra Mobility Corporation
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.